MCID: BLD052
MIFTS: 32

Blood Group Incompatibility

Categories: Blood diseases

Aliases & Classifications for Blood Group Incompatibility

MalaCards integrated aliases for Blood Group Incompatibility:

Name: Blood Group Incompatibility 12 54 43 15 71

Classifications:



External Ids:

Disease Ontology 12 DOID:4176
MeSH 43 D001787
UMLS 71 C0005806

Summaries for Blood Group Incompatibility

MalaCards based summary : Blood Group Incompatibility is related to neonatal jaundice and glucosephosphate dehydrogenase deficiency. An important gene associated with Blood Group Incompatibility is G6PD (Glucose-6-Phosphate Dehydrogenase), and among its related pathways/superpathways are Glutathione metabolism and Globo Sphingolipid Metabolism. The drugs Adenosine and Vasodilator Agents have been mentioned in the context of this disorder. Affiliated tissues include kidney, bone and bone marrow.

Related Diseases for Blood Group Incompatibility

Diseases related to Blood Group Incompatibility via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 53, show less)
# Related Disease Score Top Affiliating Genes
1 neonatal jaundice 29.9 RHD G6PD
2 glucosephosphate dehydrogenase deficiency 29.9 G6PD ABO
3 hemolytic anemia 29.6 SLC4A1 RHD RHCE G6PD
4 fetal erythroblastosis 29.3 RHD RHCE KEL ABO
5 kernicterus 29.1 SLC4A1 RHD RHCE PKM G6PD ABO
6 bilirubin metabolic disorder 10.4
7 graft-versus-host disease 10.4
8 acute graft versus host disease 10.2
9 infertility 10.2
10 pure red-cell aplasia 10.1
11 red cell aplasia 10.1
12 primary thrombocytopenia 10.1 RHD RHCE
13 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.0
14 end stage renal disease 10.0
15 acute bilirubin encephalopathy 10.0
16 plasmodium falciparum malaria 10.0 SLC4A1 G6PD ABO
17 hereditary spherocytosis 10.0 SLC4A1 RHD G6PD
18 anemia, autoimmune hemolytic 10.0 RHCE G6PD
19 beta-thalassemia 10.0 SLC4A1 RHD G6PD
20 retinohepatoendocrinologic syndrome 9.9 RHD RHCE RHBG
21 congenital nonspherocytic hemolytic anemia 9.9 PKM G6PD
22 pyruvate kinase deficiency of red cells 9.9 PKM G6PD
23 hydrops fetalis, nonimmune 9.9
24 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 9.9
25 leukemia, acute myeloid 9.9
26 aplastic anemia 9.9
27 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 9.9
28 myelodysplastic syndrome 9.9
29 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.9
30 deficiency anemia 9.9
31 polyomavirus-associated nephropathy 9.9
32 ectopic pregnancy 9.9
33 thrombosis 9.9
34 hepatic veno-occlusive disease 9.9
35 sensorineural hearing loss 9.9
36 pre-eclampsia 9.9
37 disseminated intravascular coagulation 9.9
38 acute leukemia 9.9
39 obstructive jaundice 9.9
40 kidney cortex necrosis 9.9
41 inherited metabolic disorder 9.9
42 placenta disease 9.9
43 myeloid leukemia 9.9
44 splenomegaly 9.9
45 acute liver failure 9.9
46 neonatal anemia 9.9 RHD RHCE KEL
47 hereditary elliptocytosis 9.8 SLC4A1 RHD G6PD ABO
48 pigmentation disease 9.8 PKM G6PD ABO
49 bladder sarcoma 9.7 GGT7 GGT6
50 glutathionuria 9.6 GGT7 GGT6
51 rh isoimmunization 9.6 RHD RHCE G6PD FYB1 ABO
52 otopalatodigital syndrome spectrum disorder 8.9 SLC4A1 RHD RHCE KEL FYB1 ABO
53 melnick-needles syndrome 8.9 SLC4A1 RHD RHCE KEL FYB1 ABO

Graphical network of the top 20 diseases related to Blood Group Incompatibility:



Diseases related to Blood Group Incompatibility

Symptoms & Phenotypes for Blood Group Incompatibility

Drugs & Therapeutics for Blood Group Incompatibility

Drugs for Blood Group Incompatibility (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 5, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Adenosine Approved, Investigational 58-61-7 60961
2 Vasodilator Agents
3 Anti-Arrhythmia Agents
4 Analgesics
5 Neurotransmitter Agents

Interventional clinical trials:

(showing 2, show less)
# Name Status NCT ID Phase Drugs
1 Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization Completed NCT00199628
2 Human Leucocytic Antigen Typing and Mutation of Adenosine Triphosphate Sensitive Potassium Channel Gene in Diabetic Patients Diagnosed Under the Age of One Year. Not yet recruiting NCT03169413

Search NIH Clinical Center for Blood Group Incompatibility

Cochrane evidence based reviews: blood group incompatibility

Genetic Tests for Blood Group Incompatibility

Anatomical Context for Blood Group Incompatibility

MalaCards organs/tissues related to Blood Group Incompatibility:

40
Kidney, Bone, Bone Marrow, Liver, Testes, Heart, Placenta

Publications for Blood Group Incompatibility

Articles related to Blood Group Incompatibility:

(showing 354, show less)
# Title Authors PMID Year
1
Genetic polymorphisms in Thai neonates with hyperbilirubinemia. 54 61
19397531 2009
2
Combination of ABO blood group incompatibility and glucose-6-phosphate dehydrogenase deficiency: effect on hemolysis and neonatal hyperbilirubinemia. 61 54
9628306 1998
3
Alternative donor: αß/CD19 T-cell-depleted haploidentical hematopoietic stem cell transplantation for sickle cell disease. 61
32202248 2020
4
High-Levels of 'Natural' ABO Antibodies are Produced in Female vs. Male Mice. 61
32465849 2020
5
Next Generation Sequencing-Based Fetal ABO Blood Group Prediction by Analysis of Cell-Free DNA from Maternal Plasma. 61
32110193 2020
6
Minor blood group incompatibility due to blood groups other than Rh(D) leading to hemolytic disease of fetus and newborn: a need for routine antibody screening during pregnancy. 61
32201675 2020
7
Etiology and therapeutic management of neonatal jaundice in Iran: a systematic review and meta-analysis. 61
32052364 2020
8
Impact of ABO blood group incompatibility on the outcomes of allogeneic hematopoietic stem cell transplantation. 61
31311753 2020
9
Platelet transfusion thresholds in neonatal medicine. 61
31488313 2019
10
Red blood cell transfusion burden by day 30 predicts mortality in adults after single-unit cord blood transplantation. 61
31089286 2019
11
Therapeutic apheresis in kidney transplantation: An updated review. 61
31750088 2019
12
Perinatal risk factors for type 1 diabetes revisited: a population-based register study. 61
31041471 2019
13
Preventive Effects of Probiotic Supplementation on Neonatal Hyperbilirubinemia Caused by Isoimmunization. 61
31242512 2019
14
Severe Fetal Hemolysis and Cholestasis Due to High-Titer Maternal IgG Anti-A Antibodies. 61
30872329 2019
15
Assessing the impact of ABO incompatibility on major allogeneic hematopoietic stem cell transplant outcomes: a prospective, single-center, cohort study. 61
30793098 2019
16
[Pediatric kidney transplantation: early and long-term outcomes following 1187 procedures]. 61
30789603 2019
17
[Graft failure in allogeneic hematopoietic stem cell trans-plantation]. 61
30900845 2018
18
Similar Microvascular Inflammation and Tubulointerstitial Injury in ABO-Incompatible and Matched ABO-Compatible Kidney Allografts. 61
29880350 2018
19
Kidney exchange transplantation current status, an update and future perspectives. 61
29988896 2018
20
[Clinical analysis of seven cases of rare hemolytic disease of the newborn]. 61
29783824 2018
21
Transfusion policy in allogeneic hematopoietic stem cell transplantation. 61
29724631 2018
22
Allele-selective RUNX1 binding regulates P1 blood group status by transcriptional control of A4GALT. 61
29438961 2018
23
ABO-incompatible kidney transplantation as a renal replacement therapy-A single low-volume center experience in Japan. 61
30596663 2018
24
Umbilical cord blood bilirubins, gestational age, and maternal race predict neonatal hyperbilirubinemia. 61
29856776 2018
25
Insights in Transplanting Complex Pediatric Renal Recipients With Vascular Anomalies. 61
28099405 2017
26
Hyperbilirubinemia due to minor blood group (anti-E) incompatibility in a newborn: a case report. 61
29062250 2017
27
A model of acute renal allograft rejection in outbred Yorkshire piglets. 61
28495618 2017
28
Baseline Anti-blood Group Antibody Titers and their Response to Desensitization and Kidney Transplantation. 61
28553039 2017
29
Past, present and future of kidney paired donation transplantation in India. 61
28507916 2017
30
ABO blood group incompatibility and infertility: still an open debate. 61
28104243 2017
31
Blood group incompatibility as risk of corneal rejection 61
29799709 2017
32
Oral administration of Chinese herbal medicine during gestation period for preventing hemolytic disease of the newborn due to ABO incompatibility: A systematic review of randomized controlled trials. 61
28719639 2017
33
Hemolytic Anemia and Heart Failure Caused by Anti-C and Anti-E Immunization. 61
27353998 2016
34
Carboxyhemoglobin levels as a predictor of risk for significant hyperbilirubinemia in African-American DAT(+) infants. 61
26765551 2016
35
ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioning. 61
26446051 2016
36
Prospective Surveillance of Extreme Neonatal Hyperbilirubinemia in Australia. 61
26477873 2016
37
ABO-incompatible living donor kidney transplantation without post-transplant therapeutic plasma exchange. 61
25739580 2015
38
[New strategies in living donor kidney transplantation – blood group incompatible and crossover transplantation]. 61
26227981 2015
39
Modern approaches to incompatible kidney transplantation. 61
26167458 2015
40
Prenatal Training Improves New Mothers' Understanding of Jaundice. 61
26056164 2015
41
Experience of Exchange Transfusion in a Newly Established SCANU at a Tertiary Care Hospital in Bangladesh. 61
26007247 2015
42
[Hereditary spherocytosis. Review. Part II. Symptomatology, outcome, complications, and treatment]. 61
25727830 2015
43
Four years of experience with the Australian kidney paired donation programme. 61
25408125 2015
44
A complete treatment of adult living donor liver transplantation: a review of surgical technique and current challenges to expand indication of patients. 61
25358749 2015
45
A Case of Hemolytic Disease of the Newborn due to Di (a) Antibody. 61
26682081 2015
46
Estimating the Risk of ABO Hemolytic Disease of the Newborn in Lagos. 61
26491605 2015
47
Predictive value of cord blood bilirubin for hyperbilirubinemia in neonates at risk for maternal-fetal blood group incompatibility and hemolytic disease of the newborn. 61
26518407 2015
48
[Kernicterus is preventable but still occurs]. 61
25944067 2015
49
Blood transfusion and the World Wars. 61
25819015 2015
50
Variable Clinical Presentations of ABO Incompatibility in Dizygotic Twins. 61
26803011 2015
51
Increasing access to renal transplantation in India through our single-center kidney paired donation program: a model for the developing world to prevent commercial transplantation. 61
24947741 2014
52
A questionnaire on survival of kittens depending on the blood groups of the parents. 61
24423812 2014
53
Desensitization with plasmapheresis and anti-Cd20 for ABO incompatible kidney transplantation from living donor: experience of a single center in Italy. 61
25242753 2014
54
Prehospital use of plasma: the blood bankers' perspective. 61
24662780 2014
55
CD144+ endothelial microparticles as a marker of endothelial injury in neonatal ABO blood group incompatibility. 61
24333075 2014
56
Effect of ABO blood group incompatibility on the outcome of single-unit cord blood transplantation after myeloablative conditioning. 61
24368297 2014
57
Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning. 61
24274982 2014
58
Samaritan donor interchange in living donor liver transplantation. 61
24463089 2014
59
Blood transfusion; additional historical aspects. Part 1. The birth of transfusion immunology. 61
24003949 2013
60
Matching donor to recipient in liver transplantation: Relevance in clinical practice. 61
24303088 2013
61
Ten kidney paired donation transplantation on World Kidney Day 2013: raising awareness and time to take action to increase donor pool. 61
23937166 2013
62
Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight--new perspectives? 61
23435515 2013
63
Acute kernicterus in a neonate with O/B blood group incompatibility and a mutation in SLC4A1. 61
23878048 2013
64
Outcome of kidney paired donation transplantation to increase donor pool and to prevent commercial transplantation: a single-center experience from a developing country. 61
23136032 2013
65
Maximising living donation with paediatric blood-group-incompatible renal transplantation. 61
22940908 2013
66
Homografts in aortic position: does blood group incompatibility have an impact on patient outcomes? 61
23390142 2013
67
Lessons and insights from ABO-incompatible lung transplantation. 61
23465218 2013
68
Current approaches in national kidney paired donation programs. 61
23792511 2013
69
Incidence, risk factors and causes of severe neonatal hyperbilirubinemia in the South of iran (fars province). 61
23984010 2013
70
Therapeutic apheresis in kidney transplantation: a review of renal transplant immunobiology and current interventions with apheresis medicine. 61
23420595 2013
71
Imaging diagnosis of neonatal anemia: report of two unusual etiologies. 61
24605254 2013
72
Transplantation for acute liver failure: report of results in the region of Castilla y Leon (Spain) after 10 years of activity. 61
23146476 2012
73
New Zealand's first two-pair kidney transplant chain. 61
23242403 2012
74
Severe neonatal jaundice: is it a rare event in Australia? 61
22077456 2012
75
Etiological analyses of marked neonatal hyperbilirubinemia in a single institution in Taiwan. 61
22537929 2012
76
Hemolytic disease of the newborn caused by anti-Wright (anti-Wra): case report and review of literature. 61
22397791 2012
77
Neonatal jaundice is associated with a small increase in the risk of childhood type 1 diabetes: a meta-analysis of observational studies. 61
21984049 2012
78
Hemolytic disease of the newborn- anti c antibody induced hemolysis. 61
21630066 2012
79
Outcome of exchange blood transfusions done for neonatal jaundice in abakaliki, South eastern Nigeria. 61
24027683 2012
80
Single versus multiple dose intravenous immunoglobulin in combination with LED phototherapy in the treatment of ABO hemolytic disease in neonates. 61
21617887 2011
81
Diagnostic laboratory technologies for the fetus and neonate with isoimmunization. 61
21641488 2011
82
Transplantation with kidney paired donation to increase the donor pool: a single-center experience. 61
21693207 2011
83
Medical and non-medical factors that affect voluntary living-related kidney donation: A single-center study. 61
21655164 2011
84
ABO Incompatible Kidney Transplantation-Current Status and Uncertainties. 61
22174989 2011
85
ABO blood group incompatibility: a diminishing barrier to successful kidney transplantation? 61
20979554 2010
86
[Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility]. 61
21092522 2010
87
Non-invasive fetal RHD genotyping in the first trimester of pregnancy. 61
20482298 2010
88
Exchange transfusion in neonatal hyperbilirubinaemia: a comparison between citrated whole blood and reconstituted blood. 61
20848061 2010
89
[Test for blood group incompatibility in pregnancy]. 61
20942195 2010
90
Trading with the waiting-list: the justice of living donor list exchange. 61
20394110 2010
91
Noninvasive fetal RhD genotyping from maternal blood. 61
20370586 2010
92
Mother-child blood group incompatibility and the risk of multiple sclerosis. 61
19795153 2010
93
Specific issues in living donor kidney transplantation: ABO - incompatibility. 61
20129392 2009
94
[Establishment of genotyping method for fetal ABO group from pregnant maternal peripheral blood]. 61
19840485 2009
95
[Hemolytic disease of neonates due to anti-M: report of one case and review of reports of 21 cases]. 61
20021783 2009
96
Spectrum and outcome analysis of marked neonatal hyperbilirubinemia with blood group incompatibility. 61
19664346 2009
97
Cell-free fetal DNA in the maternal serum and plasma: current and evolving applications. 61
19262379 2009
98
[Effects of lianhuang decoction in treating fetomaternal ABO blood group incompatibility]. 61
19382479 2009
99
The value of transcutaneous method of bilirubin measurement in newborn population with the risk of ABO hemolytic disease. 61
19996666 2009
100
A newborn with positive antiglobulin test whose mother took methyldopa in pregnancy. 61
19227427 2008
101
Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program. 61
18835834 2008
102
[ABO-incompatible renal transplantation--why and how?]. 61
18670749 2008
103
Surveillance of extreme hyperbilirubinaemia in Denmark. A method to identify the newborn infants. 61
18482165 2008
104
Clinical operational tolerance after kidney transplantation: a short literature review. 61
18675067 2008
105
Factors related to the durability of a homograft monocusp valve inserted during repair of tetralogy of Fallot as based on the mid- to long-term outcomes. 61
18252028 2008
106
Non-invasive prenatal diagnosis and determination of fetal Rh status. 61
18249590 2008
107
Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. 61
18236447 2008
108
[Therapeutic apheresis: selective methods]. 61
18578333 2008
109
RHD genotyping from maternal plasma: guidelines and technical challenges. 61
18425481 2008
110
A flexible national living donor kidney exchange program taking advantage of a central histocompatibility laboratory: the Dutch model. 61
19711512 2008
111
Antibody screening in repeatedly transfused patients. 61
20306683 2008
112
Blood group incompatibility in kidney transplantation: definitely time to re-examine! 61
17767439 2007
113
Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies. 61
17486341 2007
114
Repeated spontaneous abortion. Cooperative effects of ADA and ACP1 genetic polymorphisms. 61
17565542 2007
115
Large scale blood group genotyping. 61
17512235 2007
116
Massive acute haemolysis and severe neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient preterm triplets. 54
17489836 2007
117
Cadaveric liver transplantation for non-acetaminophen fulminant hepatic failure: a 20-year experience. 61
17457975 2007
118
[Contribution and selected risks of blood transfusion]. 61
17236411 2006
119
Distinguishing between recurrent primary sclerosing cholangitis and chronic rejection. 61
17051552 2006
120
A method to optimize PEG-coating of red blood cells. 61
16984140 2006
121
ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation. 61
16935028 2006
122
Early onset conjugated hyperbilirubinemia in newborn infants. 61
16741326 2006
123
[ABO-incompatible renal transplantation]. 61
16734231 2006
124
Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism. 61
16623806 2006
125
Transplantation across previously incompatible immunological barriers. 61
16441356 2006
126
ABO incompatible kidney transplantation - an analysis of UNOS Registry data. 61
16556166 2006
127
ABO blood group barrier in allogeneic bone marrow transplantation revisited. 61
16338623 2005
128
Alpha-Thalassemia 61
20301608 2005
129
Neurological and developmental outcome of neonatal jaundice and sepsis in rural Kenya. 61
16262736 2005
130
[Cross-over kidney transplantation in Germany]. 61
16294284 2005
131
[Transplantation medicine: issue of blood group incompatibility]. 61
16379239 2005
132
Neonatal anemia associated with Southeast Asian ovalocytosis. 61
16207591 2005
133
Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time. 61
16199645 2005
134
Factors influencing the survival of cryopreserved homografts. The second homograft performs as well as the first. 61
15953733 2005
135
Immune hemolysis associated with transplantation. 61
16041664 2005
136
The role of preimplantation genetic diagnosis in the management of severe rhesus alloimmunization: first unaffected pregnancy: case report. 61
15661826 2005
137
The Dutch algorithm for allocation in living donor kidney exchange. 61
15848466 2005
138
Bilirubin dosage in cord blood: could it predict neonatal hyperbilirubinemia? 61
15448807 2004
139
Longer breastfeeding is an independent protective factor against development of type 1 diabetes mellitus in childhood. 61
15037991 2004
140
Blood group incompatibility and accelerated homograft fibrocalcifications. 61
14752436 2004
141
Intrahepatic cholestasis after liver transplantation. 61
14526393 2003
142
Current status of preimplantation diagnosis for single gene disorders. 61
14567881 2003
143
HLA-DR11 in addition to donor age, gender, and major blood group incompatibility influence the incidence of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. 61
12826219 2003
144
Testing for hematologic disorders and complications. 61
12848447 2003
145
Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality. 61
12748664 2003
146
Expanding the living organ donor pool: positive crossmatch and ABO incompatible renal transplantation. 61
12736998 2003
147
Islet cell autoantibodies in cord blood from children with blood group incompatibility or hyperbilirubinemia. 61
12820693 2003
148
[Diagnostic and therapeutic proceedings in pregnancies with blood group incompatibility: A retrospective analysis over 30 years]. 61
12395291 2002
149
Hemolytic disease of the newborn due to isoimmunization with anti-E antibodies: a case report. 61
12405439 2002
150
Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia? 61
12058235 2002
151
DR3 is associated with type 1 diabetes and blood group ABO incompatibility. 61
12021139 2002
152
An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility. 61
11927726 2002
153
ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning. 61
11896336 2002
154
Coeliac disease is associated with intrauterine growth and neonatal infections. 61
11883814 2002
155
Time-dependent risk factors influencing the long-term outcome in living renal allografts: donor age is a crucial risk factor for long-term graft survival more than 5 years after transplantation. 61
11571463 2001
156
Hemograft crossmatching is unnecessary due to the absence of blood group antigens. 61
11388221 2001
157
Cholestatic diseases of liver transplantation. 61
11352120 2001
158
Postpartum chills phenomenon: is it a feto-maternal transfusion reaction? 61
11167210 2001
159
Multiple dose IVIG treatment in neonatal immune hemolytic jaundice. 61
11245352 2001
160
Development of non-ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation. Is ABO incompatibility a predisposing factor? 61
11161254 2001
161
Multiple Cerebral Emboli in a Homozygous b-Thalassaemia Patient Due to Factor V 1299 (His-Arg) 4070 A-G Mutation. 61
27263504 2000
162
[The influence of twenty years of Rh (D) factor incompatibility immunoprophylaxis on reducing the occurrence of hemolytic disease in newborns]. 61
11082940 2000
163
Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. 61
10827256 2000
164
Perinatal risk factors for childhood type 1 diabetes in Europe. The EURODIAB Substudy 2 Study Group. 61
10526738 1999
165
[Irregular blood group antibodies during pregnancy: screening is mandatory]. 61
10443258 1999
166
Severe hemolytic disease from rhesus anti-C antibodies in a surrogate pregnancy after oocyte donation. A case report. 61
10319314 1999
167
G-CSF-mobilized leukapheresis products: cellular characteristics and clinical performance in allografting. 61
10349909 1999
168
Applicability of living donor liver transplantation to high-urgency patients. 61
9921799 1999
169
The aetiology of type 1 diabetes: an epidemiological perspective. 61
9822187 1998
170
Prevention of maternal-fetal blood group incompatibility with traditional Chinese herbal medicine. 61
11245041 1998
171
[A case of ABO blood group incompatibility treated by exchange transfusion]. 61
9513341 1998
172
Viruses and other perinatal exposures as initiating events for beta-cell destruction. 61
9453289 1997
173
Massive delayed hemolysis following peripheral blood stem cell transplantation with minor ABO incompatibility. 61
9262993 1997
174
ABO blood group incompatibility in liver transplantation: a single-centre experience. 61
9152158 1997
175
Haemolytic disease of the newborn due to anti-K antibodies. 61
8789754 1996
176
Before the horse is out of the barn: fetal surgery for hydrops. 61
8822330 1995
177
Donor selection limits use of living-related liver transplantation. 61
7557860 1995
178
Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings. 61
7581080 1995
179
Differences in clinical significance of maternal-infant blood group incompatibility in mothers with blood type O, A, or B. 61
7844689 1995
180
ABO-haemolytic disease of the newborn (ABO-HDN): factors influencing its severity and incidence in Venezuela. 61
7723123 1995
181
A controlled trial of recombinant human erythropoietin after bone marrow transplantation. 61
7949088 1994
182
Removal of maternal antibodies from a woman with repeated fetal loss due to P blood group incompatibility. 61
8073488 1994
183
Bone marrow transplantation with major ABO blood group incompatibility using automated removal of red blood cells from incompatible bone marrow by CS 3000 plus. 61
8066772 1994
184
Prevalence and lack of clinical significance of blood group incompatibility in mothers with blood type A or B. 61
8021795 1994
185
Successful hematopoietic reconstitution with transplantation of erythrocyte-depleted allogeneic human umbilical cord blood cells in a child with leukemia. 61
8183934 1994
186
Non-genetic risk determinants of type 1 diabetes. 61
8001712 1994
187
Living-related liver transplantation for fulminant hepatic failure in children. 61
11271177 1994
188
Oxygenation of the human fetus as a function of hemoglobulin concentration. 61
7512340 1994
189
Automated bone marrow concentration using the Fresenius AS 104 blood cell separator. 61
9422118 1994
190
[Blood group typing in the cat]. 61
8211961 1993
191
The clinical significance of ABO blood group incompatibility. 61
8252149 1993
192
Intravenous immunoglobulin therapy in neonatal immune hemolytic jaundice. 61
8229608 1993
193
Etiological aspects of insulin-dependent diabetes mellitus: an epidemiological perspective. 61
8218832 1993
194
Ischemic-type biliary complications after orthotopic liver transplantation. 61
1618482 1992
195
Maternal-child blood group incompatibility and other perinatal events increase the risk for early-onset type 1 (insulin-dependent) diabetes mellitus. 61
1644246 1992
196
Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. 61
1586749 1992
197
N-glycolylneuraminic acid and N-acetylneuraminic acid define feline blood group A and B antigens. 61
1571562 1992
198
Comprehensive newborn screening program: ARAMCO experience, the national need and recommendations. 54
17589173 1992
199
[Placental findings in "vanishing twins"]. 61
1607118 1992
200
Vascular rejection in cardiac transplantation. A morphological study of 25 human cardiac allografts. 61
1581045 1992
201
Spectrum of neonatal hyperbilirubinemia: an analysis of 454 cases. 61
1612673 1992
202
Screening for glucose-6-phosphate dehydrogenase deficiency can prevent severe neonatal jaundice. 61
1283668 1992
203
Bone marrow fractionation by the haemonetics system: reduction of red cell mass before marrow freezing, with special reference to pediatric marrow volumes. 61
1413659 1992
204
[Pathology of the placenta. IX. Intrauterine fetal death. Regression. Edema and fibrosis of the villous stroma]. 61
1596479 1992
205
Diagnostic utility of the pre-incubated acidified glycerol lysis test in haemolytic and non-haemolytic anaemias. 61
1761123 1991
206
Congenital haemolytic anaemia in a low birth weight infant due to congenital stomatocytosis. 61
1868910 1991
207
A preliminary report on ABO incompatible bone marrow transplant. 61
1799251 1991
208
[Neonatal blood group incompatibility due to anti-M antibodies]. 61
2052099 1991
209
Histopathology of hyperacute rejection of the heart: experimental and clinical observations in allografts and xenografts. 61
2031919 1991
210
High-dose intravenous gammaglobulin therapy for neonatal immune haemolytic jaundice due to blood group incompatibility. 61
1709770 1991
211
Granulocytic sarcoma of the ileum treated by bone marrow transplantation. 61
2029076 1991
212
[Serum ABO immune antibodies in 1944 pregnant women]. 61
1900749 1991
213
Relationship between blood groups and sex ratio of the newborn. 61
1841485 1991
214
Frequency and inheritance of A and B blood types in feline breeds of the United States. 61
1997588 1991
215
[Modern diagnosis and therapy of fetomaternal blood group incompatibility]. 61
2128174 1990
216
ABO blood group incompatibility and primary tooth discoloration. 61
2639328 1989
217
Hemoglobin by first derivative spectrophotometry: extent of hemolysis in plasma and serum collected in vacuum container devices. 61
2802517 1989
218
Dermal hematopoiesis in neonates: report of five cases. 61
2546982 1989
219
The role of ABO blood group compatibility in heart transplantation between closely related animal species. An experimental study using the vervet monkey to baboon cardiac xenograft model. 61
2645470 1989
220
Bone marrow transplantation in Polish conditions. Method for removal of red cells from the transplant in the case of major blood group incompatibility. 61
2639626 1989
221
[Comment on H. Wilken: Current problems of blood group incompatibility in pregnancy, Zent.bl. Gynäkol. 110 (1988) 1-11]. 61
2499137 1989
222
[Improved intrauterine diagnosis and therapy of blood group incompatibility]. 61
2482232 1989
223
[Response to the comment by N. Lahmann on "Current problems of blood group incompatibility in pregnancy"]. 61
2499138 1989
224
[Problems of children with hemolytic disease of the newborn, caused by Rh and ABO blood group incompatibility, treated by exchange transfusion]. 61
3150889 1988
225
[Specific complex prenatal care of women with ABO blood group incompatibility at an outpatient maternity clinic]. 61
3262316 1988
226
[Effectiveness of phototherapy in the treatment of jaundice caused by ABO and Rh blood group incompatibility]. 61
3149117 1988
227
[Current problems of blood group incompatibility in pregnancy]. 61
3281396 1988
228
Cardiac allotransplantation across major blood group barriers in the baboon. 61
3065510 1988
229
The glycosphingolipid composition of the placenta of a blood group P fetus delivered by a blood group Pk1 woman and analysis of the anti-globoside antibodies found in maternal serum. 61
3341739 1988
230
Immunologic transfusion reactions. 61
3067489 1988
231
ABO blood group incompatible kidney transplantation: a case report and review of the literature. 61
3327640 1987
232
[Gynecological immunology. 6. Blood group incompatibility in pregnancy]. 61
3682327 1987
233
Immunogenetic studies of maternal-fetal relationships: a review: why newborn rhesus monkeys don't get hemolytic disease. 61
3333354 1987
234
[Detection of blood group substances in chorionic villi for the early diagnosis of mother-fetus blood group incompatibility]. 61
3478176 1987
235
Human cadaver renal transplantation in the presence of ABO blood group incompatibility. 61
3296359 1987
236
ABO blood group incompatibility and infertility in Nigerian couples. 61
3583322 1987
237
Preparation of red-blood-cell-depleted marrow for ABO-incompatible marrow transplantation by density-gradient separation using the IBM 2991 blood cell processor. 61
3536547 1987
238
Formation of bilirubin conjugates in human newborns. 61
3774408 1986
239
Familial occurrence of hemolytic disease of the newborn due to AO blood group incompatibility. 61
3972392 1985
240
AB0 blood group incompatibility and inbreeding effects: evidence for an interaction. 61
3972416 1985
241
Correlation of humoral immunity to Lewis blood group antigens with renal transplant rejection. 61
6367166 1984
242
Transfusion reactions in cats due to AB blood group incompatibility. 61
6635340 1983
243
[Remote future of infants with perinatal hemolytic disease due to fetomaternal blood group incompatibility]. 61
6558877 1983
244
Blood group incompatibility in bone marrow transplantation. 61
6346604 1983
245
[Serum alpha fetoprotein concentration in pregnant women with Rh blood group incompatibility]. 61
6193035 1983
246
[Fetal monitoring during induction of labor with prostaglandin E2 in parturients with blood group incompatibility]. 61
6407213 1983
247
Reduced optimality in pre- and perinatal conditions in dyskinetic cerebral palsy--distribution and comparison to controls. 61
6835479 1983
248
Fetomaternal blood group incompatibility studies in placental intervillous thrombosis. 61
6672809 1983
249
Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion. 61
7046847 1982
250
[Adaptation of children, born to mothers with blood group incompatibility, without clinical signs of hemolytic disease of newborn]. 61
6803224 1982
251
[Reverse triiodothyronine concentration in the amniotic fluid in blood group incompatibility]. 61
6820945 1982
252
[Diagnosis of fetal erythroblastosis and therapeutic procedures in blood group incompatibility]. 61
6814987 1982
253
[Progress in the diagnosis and therapy of blood group incompatibility in pregnancy]. 61
6171494 1981
254
ABO blood group incompatibility differentials in reproductive performance with respect to maternal age and parity among Dawoodi Bohras of Udaipur, Rajasthan. 61
7341446 1981
255
Exchange transfusion in neonatal myasthenia gravis. 61
7195520 1981
256
[Acid phosphatase activity in the neutrophils and peripheral lymphocytes in normal pregnancy and pregnancies complicated by RH-HR blood group incompatibility and toxemia]. 61
6790373 1981
257
Renal transplant in a patient with major donor-recipient blood group incompatibility: reversal of acute rejection by the use of modified plasmapheresis. 61
7015598 1981
258
Current clinical concepts in hemolytic disease and blood group incompatibility. 61
6273933 1981
259
Current concepts in hemolytic disease and blood group incompatibility. 61
6969353 1980
260
[Value of cardiotocography for detection of fetal risk in blood group incompatibility]. 61
6776009 1980
261
[Aspects of ABO blood group incompatibility in the pre- and postnatal periods]. 61
6774626 1980
262
[Experience obtained from intra-uterine foetal transfusion to cope with severe rhesus-caused haemolytic disease of foetus - ten-year report (author's transl)]. 61
7445825 1980
263
[Prevention of RH-HR blood group incompatibility]. 61
120092 1979
264
Preeclampsia, neonatal asphyxia and ABO blood group incompatibility. 61
457202 1979
265
Autologous blood transfusions and pregnancy. 61
424131 1979
266
Amniotic fluid creatinine and uric acid levels in high risk pregnancy. 61
550699 1979
267
[Results of treatment of Rh blood group incompatibility with plasmapheresis]. 61
121293 1979
268
Blood group incompatibility and cervical hostility in relation to sterility. 61
622233 1978
269
Factors influencing jaundice in immigrant Greek infants. 61
626518 1978
270
[Diagnostic value of determination of optical density of bilirubin in rhesus blood-group incompatibility]. 61
412320 1977
271
Erythroblastosis models. II. Materno-fetal incompatibility in chimpanzee. 61
556709 1977
272
Significance of HLA and blood-group incompatibility in spontaneous abortion. 61
819191 1976
273
[LP-X in newborns: increased incidence of positive tests without cholestasis (author's transl)]. 61
5573 1976
274
Unexplained infertility and ABO blood group incompatibility. 61
1027620 1976
275
[Cellular immunity in newborn infants with hyperbilirubinemia]. 61
58819 1976
276
[Maternal-fetal blood group incompatibility in the light of recent statistical and immunohematological data]. 61
815851 1976
277
A prospective clinicopathological study of 1,108 cases of antenatal fetal death. 61
1254436 1976
278
Anti-PP1Pk (anti-Tja) and habitual abortion. 61
1237418 1975
279
[Surveillance of pregnant women with Rh factors and blood group incompatibility]. 61
817503 1975
280
Survey of neonatal jaundice in Port Moresby. 61
4534259 1974
281
[Leukemia of a still-born child (author's transl)]. 61
4466210 1974
282
[Proceedings: Blood group incompatibility and fertility]. 61
4205221 1973
283
[Hydrops fetalis without hydrops placentae and blood group incompatibility in women with pregnancy toxicosis]. 61
4760990 1973
284
Practical effects of blood group incompatibility between mother and fetus. 61
4630468 1973
285
Blood group incompatibility between mother and foetus. 61
4114342 1972
286
Practical effects of blood group incompatibility between mother and fetus. 61
5062951 1972
287
Evaluation of a simple method for determination of IgG titre anti-A or-B in cases of possible ABO blood group incompatibility. 61
5032414 1972
288
Phototherapy of jaundice in newborn infant. I. ABO blood group incompatibility. 61
5132302 1971
289
Blood group incompatibility and immunoglobulin levels. 61
4104378 1971
290
[Problems of blood group incompatibility involving newborn infants]. 61
5468467 1970
291
[Blood group incompatibility in childhood]. 61
4996901 1970
292
[Brain damage from blood group incompatibility]. 61
4994455 1970
293
[Blood group incompatibility. Pathological anatomical report]. 61
5512145 1970
294
[Blood group incompatibility. Introduction and serologic-genetic report]. 61
4105436 1970
295
A clinical classification of the mechanisms of perinatal wastage. 61
5414922 1970
296
[Maternal-fetal blood group incompatibility]. 61
5198900 1970
297
[Blood group incompatibility between the mother and the child, hyperbilirubinemia of the newborn infant and exchange transfusion]. 61
5510955 1970
298
The role of Xg a blood group incompatibility in fetal loss--twin study. 61
5502030 1970
299
[Possible relations between blood group incompatibility in ABO system and natural prezygotic selection]. 61
5518071 1970
300
ABO blood group incompatibility in renal transplantation. 61
4908385 1969
301
A laboratory survey of A-B-O blood-group incompatibility and neonatal jaundice. 61
5387801 1969
302
A hemolytic neonatal disease in swine associated with blood group incompatibility. 61
5812891 1969
303
ABO blood group incompatibility in human renal homotransplantation. 61
4885605 1969
304
[Testing of neonate blood in establishing the diagnosis of hemolytic disease in the newborn according to ABO blood group incompatibility]. 61
5307842 1969
305
[Blood group incompatibility in the ABO and Rh(D) systems in women with a blood transfusion anamnesis]. 61
4193011 1969
306
Immunology of pregnancy: significance of blood group incompatibility between mother and foetus. 61
4178362 1968
307
[The remote results of exchange transfusion in children for feto-maternal blood group incompatibility. (Apropos of 110 cases)]. 61
5761167 1968
308
Problem of ABO blood group incompatibility and sterility: the effect of blood group antibody on spermatozoa. 61
5675878 1968
309
[Several problems of pregnancy complicated by blood group incompatibility]. 61
4973992 1968
310
[The antimetabolites in isoimmunization caused by materno-fetal Rh blood group incompatibility]. 61
4391038 1968
311
[Problem of feto-maternal blood group incompatibility]. 61
5695348 1968
312
An investigation of a proposed mechanism for infertility based on ABO blood group incompatibility. 61
5638075 1968
313
Successful human cadaveric renal homograft with major blood-group incompatibility. 61
12371437 1967
314
[Blood group incompatibility and abortion and premature labor]. 61
6015127 1966
315
Antenatal immunisation by the Rh factor and ABO blood group incompatibility between mother and child. 61
4960906 1966
316
[On selection of children by ABO blood group incompatibility between mother and child]. 61
5910532 1966
317
Recent advances: blood group incompatibility of the newborn. 61
4379041 1966
318
[Physiopathology and treatment of fetal hydrops caused by Rh blood group incompatibility]. 61
4957981 1966
319
[The role of the factors of blood group incompatibility of mother and fetus]. 61
5999650 1966
320
[Prevention and treatment of transfusion incidents due to blood group incompatibility]. 61
4957280 1965
321
[Some remarks on the management of pregnancy with blood group incompatibility]. 61
5837232 1965
322
[BLOOD GROUP INCOMPATIBILITY AND ITS EARLY SERODIAGNOSIS]. 61
14266806 1965
323
[A CASE OF SEVERE ANEMIA IN AN INFANT CAUSED BY MAIN BLOOD GROUP INCOMPATIBILITY]. 61
14287696 1965
324
[BILATERAL RENAL CORTICAL NECROSIS DUE TO BLOOD GROUP INCOMPATIBILITY IN PREGNANT RABBITS]. 61
14329806 1964
325
[INDUCED COMPLICATIONS OF LATE PREGNANCY THROUGH BLOOD GROUP INCOMPATIBILITY BETWEEN FEMALE RABBIT AND ITS FETUS]. 61
14319060 1964
326
Endogenous formation of carbon monoxide in newborn infants. I. Non-icteric and icteric infants without blood group incompatibility. 61
13971342 1963
327
[CONDUCT TO FOLLOW IN CASES OF ACCIDENT DUE TO BLOOD GROUP INCOMPATIBILITY]. 61
14112668 1963
328
[Blood group incompatibility as a fetal indication for cesarean section]. 61
14027795 1963
329
[Fetomaternal blood group incompatibility]. 61
14014316 1963
330
[Technic of exchange transfusion in the case of blood group incompatibility]. 61
13895712 1962
331
Blood group incompatibility as a cause of spontaneous abortion. 61
13786753 1961
332
[The significance of blood group incompatibility of mother and fetus in premature infants]. 61
13685692 1961
333
[A-O and B-O blood group incompatibility in children of the same mother]. 61
15445390 1961
334
The significance of maternal--foetal blood group incompatibility in premature infants. 61
13685691 1961
335
Hydrops foetalis without blood group incompatibility but associated with hydramnios. 61
13818999 1960
336
[Experience with the treatment of blood group incompatibility in newborn infants]. 61
13848581 1960
337
ABO blood group incompatibility. 61
13829073 1960
338
[The problem of induced abortion & sterilization in case of blood group incompatibility of mother & child]. 61
13497148 1957
339
Unexpected blood group incompatibility, revealed by 51 Crlabelled red cells. 61
13495344 1957
340
[Prevention of non-specific titer increases in blood group incompatibility; a contribution to prevention of morbus hemolyticus neonatorum]. 61
13365887 1956
341
[Obstructive jaundice in hemolytic disease of the newborn due to blood group incompatibility]. 61
13379791 1956
342
A five-year study of prematurity. 61
13304692 1956
343
The prevention of kernicterus in the premature; hyperbilirubinaemia unassociated with blood group incompatibility. 61
13319838 1956
344
[Icterus neonatorum and blood group incompatibility]. 61
13300263 1955
345
[Maternal-fetal Rh and other blood-group incompatibility]. 61
13255302 1955
346
[An animal model of human erythroblastosis; experimental erythroblastosis in guinea pig due to blood group incompatibility]. 61
13220151 1954
347
[Fate of children from pregnancies with blood group incompatibility]. 61
13133495 1953
348
[Blood group incompatibility as cause of icterus neonatorum]. 61
13060088 1953
349
Kernicterus without prematurity or blood-group incompatibility. 61
14925409 1952
350
Blood group incompatibility in abortion and sterility. 61
14856743 1951
351
[On the release of the reaction to blood group incompatibility]. 61
14934183 1951
352
[Practical method of making cross test for prevention of transfusion complications due to blood group incompatibility]. 61
14788828 1950
353
[Blood group incompatibility in mother and fetus; methods for its prevention and therapy]. 61
14781557 1950
354
Blood-Group Incompatibility in Rabbit Embryos and in Man. 61
16587885 1934

Variations for Blood Group Incompatibility

Expression for Blood Group Incompatibility

Search GEO for disease gene expression data for Blood Group Incompatibility.

Pathways for Blood Group Incompatibility

GO Terms for Blood Group Incompatibility

Cellular components related to Blood Group Incompatibility according to GeneCards Suite gene sharing:

(showing 2, show less)
# Name GO ID Score Top Affiliating Genes
1 integral component of membrane GO:0016021 9.28 SLC4A1 RHD RHCE RHBG KEL GGT7
2 cytoplasmic side of plasma membrane GO:0009898 8.96 SLC4A1 G6PD

Biological processes related to Blood Group Incompatibility according to GeneCards Suite gene sharing:

(showing 5, show less)
# Name GO ID Score Top Affiliating Genes
1 glutathione metabolic process GO:0006749 9.33 GGT7 GGT6 G6PD
2 glutathione biosynthetic process GO:0006750 9.32 GGT7 GGT6
3 leukotriene D4 biosynthetic process GO:1901750 9.26 GGT7 GGT6
4 ammonium transmembrane transport GO:0072488 9.13 RHD RHCE RHBG
5 ammonium transport GO:0015696 8.8 RHD RHCE RHBG

Molecular functions related to Blood Group Incompatibility according to GeneCards Suite gene sharing:

(showing 6, show less)
# Name GO ID Score Top Affiliating Genes
1 transferase activity, transferring hexosyl groups GO:0016758 9.37 ABO A4GALT
2 ankyrin binding GO:0030506 9.32 SLC4A1 RHBG
3 glutathione hydrolase activity GO:0036374 9.26 GGT7 GGT6
4 leukotriene C4 gamma-glutamyl transferase activity GO:0103068 9.16 GGT7 GGT6
5 hypoglycin A gamma-glutamyl transpeptidase activity GO:0102953 8.96 GGT7 GGT6
6 ammonium transmembrane transporter activity GO:0008519 8.8 RHD RHCE RHBG

Sources for Blood Group Incompatibility

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....